Cycle on Jun 8, 2026

I will start by listing the topic's open threads to understand what is currently being tracked or needs resolution, and reading the existing notes on the topic to see what has already been established.

I will read the existing notes to understand the current state of findings on this topic.

I see we have notes on CVS Health, UnitedHealth/Optum, Cigna/Evernorth, Humana, Centene, and regulatory/legislative crackdowns on PBMs. The core of the user's brief is to "adjudicate how US health insurers actually earn their profits — the gap between 'they're hated' and a clear-eyed read of the economics." Let's pull public market views for the core tickers mentioned: UNH, CVS, CI, HUM, CNC, and ELV (Elevance Health). Wait, Elevance (ELV) is missing a dedicated note! Let's pull market views for them to understand their current performance, multiples, and segments. Let's call `market_view` for UNH, CVS, CI, HUM, CNC, and ELV. I can do them one by one or in parallel as I plan my actions. I will start by calling `market_view` for UNH, ELV, and CVS first.

I will continue gathering market views for the remaining core managed-care companies (Elevance, Cigna, and Humana) to get a clear picture of their financial trajectories, segment performance, and valuation.

I will now call `market_view` for CVS, CI, HUM, and CNC to complete the dataset of the major managed-care companies.

I will now call `market_view` for Cigna (CI), Humana (HUM), and Centene (CNC).

I will now call `market_view` for Humana (HUM) and Centene (CNC).

I will now call `market_view` for Centene (CNC).

Let's analyze the thread: "Track the upcoming June 2026 Wakely Consulting Group risk adjustment data for Centene (CNC) to verify if the risk adjustment receivable supports its 4% Marketplace pretax margin target, and monitor the October 2026 CMS Star Ratings announcements for Humana (HUM) and UnitedHealth (UNH) to assess their 2027/2028 Medicare Advantage margin recovery pathways." Wait, today is June 8, 2026. Let's see if there is any news on the June 2026 Wakely Consulting Group risk adjustment data or if we can do a web search on this. Also, the user wants us to "Adjudicate how US health insurers actually earn their profits — the gap between 'they're hated' and a clear-eyed read of the economics. Stay analytical and grounded in the filings." Let's do some search on Elevance Health's Q1 2026 earnings, segments (Carelon vs. Health Benefits), and margins, and then do a search on the broader question of "how US health insurers earn their profits", segment margins, the role of PBMs, and vertical integration. Let's do a web search first on: `Elevance Health Q1 2026 earnings Carelon segment profit` or similar. Let's do a search to get the details of Elevance Health's segments and margins.

Let's fetch the Elevance Health Q1 2026 earnings press release (`https://www.elevancehealth.com/newsroom/elv-quarterly-earnings-q1-2026`) and also look at the PDF transcript or yahoo finance transcript to see exactly what Carelon's numbers were and how they compare to Health Benefits, and how this relates to the "where the profit actually comes from" thesis. Let's do a `web_fetch` on `https://www.elevancehealth.com/newsroom/elv-quarterly-earnings-q1-2026`.

Let's analyze Elevance Health's segments: - **Health Benefits segment**: Operating revenue was $42.5 billion in Q1 2026. Operating gain was $2.2 billion. That's an operating margin of $2.2B / $42.5B = 5.17%. - **Carelon segment** (which is CarelonRx—their PBM—and Carelon Services): Operating revenue was $18.0 billion in Q1 2026. Operating gain was $1.1 billion. That's an operating margin of $1.1B / $18.0B = 6.11%. Wait, what is Carelon's revenue and operating gain? Note that Carelon sells to both external customers and internally to Elevance's Health Benefits segment. Let's look at the elimination of intersegment revenues or how Carelon's earnings are structured. Let's see if we can search for Elevance's Q1 2026 10-Q or earnings transcript to see how much of Carelon's revenue is intersegment, and how Carelon serves as a major profit engine. Let's do a search.

Let's search for the Q1 2026 PDF from Elevance Health to see the segment table. Let's search for `"Health Benefits" "Carelon" "eliminations"` or `"intersegment"` in the context of Q1 2026. Or let's search for `Elevance Health Q1 2026 Form 10-Q intersegment` or `segment`. This will help us quantify how much of Carelon's revenue is internal vs. external, which directly addresses the thesis: "explain where the money actually is — vertical integration, internal profit shifting, and the difference between the regulated MLR and the unregulated service margin." Let's do a web search.

Let's fetch `https://www.businesswire.com/news/home/20260421687833/en/Elevance-Health-Reports-First-Quarter-2026-Results-Raises-Full-Year-Guidance` to get the actual numbers from the tables, which will contain Segment Revenues, Eliminations, Operating Gains, and so on. This will give us excellent primary material.

The segment highlights show: - **Health Benefits**: - Q1 2026 Operating Revenue: $42.5 Billion (vs. $41.4B in Q1 2025) - Q1 2026 Operating Gain: $2.2 Billion (vs. $2.2B in Q1 2025) - Operating Margin: 5.1% (vs. 5.4% in Q1 2025) - **Carelon**: - Q1 2026 Operating Revenue: $18.0 Billion (vs. $16.7B in Q1 2025) - Q1 2026 Operating Gain: $1.1 Billion (vs. $1.1B in Q1 2025) - Operating Margin: 5.9% (vs. 6.6% in Q1 2025) Wait, what is the elimination? Let's search for the actual table with eliminations in the Press Release. The Business Wire press release has a table that was truncated or omitted. Let's do a search on the SEC filing or some source that has the segment elimination table to see how much of Carelon's revenue is intersegment. Let's search for: `Elevance Health Q1 2026 segment eliminations "Carelon"` or `Carelon "eliminations" 10,965` (since the Yahoo Finance snippet said "Eliminations. (10,965)"). Let's see if we can find this.

I will fetch the SEC filing containing the Q1 2026 earnings release for Elevance Health to get the exact segment revenue and elimination figures, which will show how much of Carelon's revenue is generated internally vs. externally.

Let's analyze the segment details in this filing: - **Operating Revenue**: - Health Benefits: $42,490 million ($42.49B) - CarelonRx (PBM): $10,600 million ($10.60B) - Carelon Services: $7,365 million ($7.37B) - Corporate & Other: $4 million - **Eliminations**: $(10,965) million ($(10.97B)) - **Total Operating Revenue**: $49,494 million ($49.49B) Wait, this is fascinating! The Carelon segments have combined segment revenues of: - CarelonRx: $10,600 million - Carelon Services: $7,365 million - Total Carelon segment revenue: $17,965 million (~$18.0 billion) - But **Eliminations** are $(10,965) million! This means that out of $17,965 million of Carelon's total revenue, $10,965 million is **intersegment revenue** (i.e., revenue from selling services and products to Elevance's own Health Benefits segment). That is 61.0% ($10,965M / $17,965M) of Carelon's total revenue that comes from internal transactions! And what about the **Operating Gains**? - Health Benefits segment: $2,157 million on $42,490 million of revenue. Margin: 5.08%. - CarelonRx segment: $582 million on $10,600 million of revenue. Margin: 5.49%. - Carelon Services segment: $470 million on $7,365 million of revenue. Margin: 6.38%. - Total Carelon operating gain: $582M + $470M = $1,052 million (~$1.05 billion). - Total segment operating gain (Health Benefits + CarelonRx + Carelon Services): $2,157M + $1,052M = $3,209 million. Wait, Carelon's operating gain ($1,052M) represents 32.8% of the total segment operating gains ($3,209 million). And how much of Carelon's operating gain is generated through internal profit-shifting? In managed care, intersegment profits are often not eliminated at the segment level but are eliminated on a consolidated GAAP basis if they are intercompany, or they are recognized as service-segment gains. Wait! Let's check how the intercompany profits are handled. In Elevance's segment accounting, "Operating gain/loss... does not include net investment income... as these items are managed in a corporate shared service environment." But they do not eliminate intersegment *profits* from segment reporting (only intersegment *revenues* are eliminated to arrive at consolidated operating revenue). This means that a substantial portion of Carelon's $1.05 billion in operating gain is earned by charging its own Health Benefits segment for pharmacy benefits (CarelonRx) and clinical/behavioral services (Carelon Services). This is a beautiful, concrete example of how vertical integration works to capture margin outside of the regulated insurance entity (where Medical Loss Ratio, or MLR, caps the profit margin). Let's do a search on how other managed care companies do this, especially UnitedHealth (Optum) and CVS (Caremark/Aetna). Wait! Let's check the open thread: "Track the upcoming June 2026 Wakely Consulting Group risk adjustment data for Centene (CNC) to verify if the risk adjustment receivable supports its 4% Marketplace pretax margin target, and monitor the October 2026 CMS Star Ratings announcements for Humana (HUM) and UnitedHealth (UNH) to assess their 2027/2028 Medicare Advantage margin recovery pathways." Wait, since today is June 8, 2026, let's search if there has been any release of the "Wakely risk adjustment data" or "CMS risk adjustment" for 2025/2026. Let's do a web search.

This is extremely interesting! Let's see what the Perplexity summary or other sources say about the Q1 2026 earnings call of Centene (CNC) and the "Wakely data". Let's do a search for: `Centene "Wakely" Q1 2026 earnings call transcript` or `Centene Q1 2026 earnings transcript "Wakely"`. This is exactly the data we need to check if the June 2026 Wakely risk adjustment data has been discussed, or what the expectations are. Let's do a web search.

Let's fetch the Centene Q1 2026 Earnings Transcript (`https://www.fool.com/earnings/call-transcripts/2026/04/28/centene-cnc-q1-2026-earnings-transcript/`) to read the exact quotes about the Wakely report and risk adjustment receivables, and how it relates to their 4% Marketplace pretax margin target. This is of high quality and directly resolves the thread! Let's do a `web_fetch`.

Wait, let's search specifically for the word "Wakely" inside the transcript of the Centene Q1 2026 earnings call, or look for mentions of "Wakely" in the full transcript on other sites, or search within this page if there are any other occurrences. Let's do a search for: `Centene Q1 2026 earnings transcript "Wakely"` to find the exact text or quotes. Let's do a web search.

Let's search for "Wakely" in the transcript to find the exact quotes. Let's write a query that searches for the exact text on the Motley Fool page or similar pages. Wait, let's do a search on Google or Bing for the exact quote containing "Wakely" in the Centene Q1 2026 call. Let's do a search.

Let's fetch `https://healthworksai.com/payor-insights/centene-corporation-q1-2026-earnings-call-insight/` and `https://www.investing.com/news/transcripts/earnings-call-transcript-centene-q1-2026-results-exceed-expectations-93CH-4641867` or `https://www.spglobal.com/market-intelligence/en/news-insights/articles/2026/5/centene-shares-jump-after-q1-2026-earnings-as-health-insurers-outperform-101239949` to see what comments were made on the "June Wakely report" and how it impacts the 4% Marketplace pretax margin target. Let's do a `web_fetch` on `https://healthworksai.com/payor-insights/centene-corporation-q1-2026-earnings-call-insight/`.

This is incredible! We have found the exact details of the thread: - **Centene (CNC) Wakely Consulting Group Risk Adjustment Data Thread**: - The thread asks to track the upcoming June 2026 Wakely risk adjustment data to verify if the risk adjustment receivable supports its 4% Marketplace pretax margin target. - The Q1 2026 earnings call insight shows that Centene has conservatively booked a ~3% pre-tax Marketplace margin in guidance (vs. its original 4% target), withholding the full receivable upside pending the June 2026 Wakely data. - CEO Sarah London stated: *"We have not accounted for the full range of what that receivable could be in the updated guidance, but that range does wrap around our original 4% target margin for 2026 in Marketplace and frankly higher than that at the top end."* - This is a direct dated catalyst! We can register a watch for this: the June 2026 Wakely data. Wait, since today is June 8, 2026, the June 2026 Wakely report is expected to be released this month. Let's do a search to see if the June 2026 Wakely report has been released yet. Let's search `Wakely risk adjustment report June 2026` or `Wakely National Risk Adjustment Reporting 2026`. Let's do a web search.

The June Wakely report has not been released yet or is not yet publicly indexable as of June 8, 2026 (or it's an ongoing process where the data is distributed to carriers first, and then CMS releases its official summary in late June or early July). Wait, let's look at the CMS risk adjustment report release timeline. Usually, CMS releases the final risk adjustment report for the prior benefit year (2025) in late June or early July (historically around June 30 or July 1). Let's search for `CMS risk adjustment report 2025 benefit year release date` or `CMS risk adjustment report release date 2026`. Let's do a web search.

I have exhausted my web search budget, but I have gathered incredibly detailed, concrete evidence from the official filings, market views, and earnings call transcripts of Elevance Health and Centene Corporation to write highly rigorous findings and resolve the current thread or record watches. Let's review the core entities and the thesis: 1. **Elevance Health (ELV) and Carelon Vertical Integration**: - Elevance's Q1 2026 earnings release and SEC Form 10-Q reveal that its Carelon segment (CarelonRx PBM and Carelon Services) generated $17.97 billion in total segment revenue in Q1 2026, but $10.97 billion (61.0%) was **intersegment revenue** (eliminated on consolidation) from serving its own Health Benefits segment. - Carelon generated $1.05 billion in operating gain in Q1 2026 ($582 million from CarelonRx and $470 million from Carelon Services), representing 32.8% of the total segment operating gains of the company ($3.21 billion). - This illustrates that nearly a third of Elevance's segment operating profit is captured through its vertically integrated services arm, largely by charging its own regulated insurance business (Health Benefits, which had an operating margin of 5.1% compared to CarelonRx's 5.5% and Carelon Services' 6.4%). - This directly supports the thesis that managed care organizations shift and capture margin outside of the regulated Medical Loss Ratio (MLR) constraints of the health insurance business. 2. **Centene (CNC) and the Marketplace Risk Adjustment Receivable**: - In its Q1 2026 earnings call, Centene reported an adjusted EPS of $3.37 (beating consensus by 58%) and raised its full-year EPS guidance to >$3.40. - However, the company has conservatively booked a ~3% pre-tax Marketplace margin in its guidance, down from its original 4% target, because it has withheld the full anticipated risk adjustment receivable for its higher-acuity silver-tier membership post-eAPTC expiration. - The June 2026 Wakely Consulting Group report is the critical upcoming catalyst that will either confirm this receivable and provide upside "wrapping around the original 4% target and frankly higher" (per CEO Sarah London) or present a downside risk if the receivable does not materialize. Let's look at the existing notes and check if we can update them or write fresh ones. The prior notes include: - `regulatory-pbm-reform-vertical-integration-cracks` (Regulatory and Legislative Crackdown on PBMs and Vertical Integration) - `unitedhealth-optum-vertical-integration-medicare-advantage` (UnitedHealth and Optum Vertical Integration & Strategic Medicare Advantage Contraction) - `cvs-health-caremark-aetna-margin-recovery` (CVS Health: Aetna's Margin Recovery and Caremark's Pricing Transition) - `centene-medicaid-hbr-2027-policy-risk` (Centene: Medicaid Cost Recovery and the 2027 Work Requirement Policy Risk) - `humana-medicare-advantage-margin-compression` (Humana's Medicare Advantage Margin Compression and the 2027 Benefit Cliff) - `cigna-evernorth-pivot-commercial-focus` (Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus) Let's write a fresh note on **Elevance Health (Carelon)** since there isn't one yet! We can title it: `elevance-health-carelon-vertical-integration-internal-margins`. And we can write a note on **Centene's Marketplace Risk Adjustment and the Wakely Catalyst** to update or complement its existing note, or we can update the existing note `centene-medicaid-hbr-2027-policy-risk` or write a new one `centene-marketplace-risk-adjustment-wakely-catalyst` to capture this specific Marketplace and Wakely story. Let's write a new note for Centene's Marketplace and Wakely story as it's a distinct theme from the Medicaid work requirement policy risk. Let's draft the Elevance note: Slug: `elevance-health-carelon-vertical-integration-internal-margins` Title: `Elevance Health: Carelon and the Internal Profit Engine of Vertical Integration` Let's draft the Centene note: Slug: `centene-marketplace-risk-adjustment-wakely-catalyst` Title: `Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalyst` Let's call `write_note` for the Elevance note. Since we pulled the data from `/markets/ELV/2026/06/02` and the SEC Form 10-Q/press release, we will cite them. Let's write the note.

Now let's write the Centene note on Marketplace and the Wakely catalyst. Let's draft the Centene note: Slug: `centene-marketplace-risk-adjustment-wakely-catalyst` Title: `Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalyst` Let's call `write_note` for this note. We will cite `/markets/CNC/2026/06/02` and the Q1 2026 earnings transcript. Let's write the note.

Now let's look at the open thread: "Track the upcoming June 2026 Wakely Consulting Group risk adjustment data for Centene (CNC) to verify if the risk adjustment receivable supports its 4% Marketplace pretax margin target, and monitor the October 2026 CMS Star Ratings announcements for Humana (HUM) and UnitedHealth (UNH) to assess their 2027/2028 Medicare Advantage margin recovery pathways." Wait! The thread is a "question" kind of thread that is ongoing because: 1. The June 2026 Wakely risk adjustment data is coming up (today is June 8, 2026, so it has not been fully resolved yet, but we have updated the expectations and set up the thesis). 2. The October 2026 CMS Star Ratings are also a future catalyst. Let's register a forward-looking watch for these two catalysts! Instead of leaving them in a generic thread, we can register dedicated watches so that future cycles can check and resolve them. Let's call `record_watch` for: 1. **Centene's June 2026 Wakely Risk Adjustment Data**: - Watch type: `dated_catalyst` - Cardinality: `one_shot` - Entity: `CNC` - Title: `Centene June 2026 Wakely Risk Adjustment Data Release` - Description: `Monitor the release of the June 2026 Wakely risk adjustment data to verify if Centene's risk adjustment receivable supports its 4% Marketplace margin target.` - Fire date: `2026-06-30T00:00:00Z` (approximate date for the Wakely/CMS final risk adjustment report). 2. **Humana and UnitedHealth October 2026 CMS Star Ratings**: - Watch type: `dated_catalyst` - Cardinality: `one_shot` - Entity: `HUM` - Title: `CMS Star Ratings October 2026 Announcement` - Description: `Monitor the October 2026 CMS Star Ratings announcements for Humana (HUM) and UnitedHealth (UNH) to assess their 2027/2028 Medicare Advantage margin recovery pathways.` - Fire date: `2026-10-15T00:00:00Z` (approximate date for Star Ratings). Let's record these two watches! This is a much better way to handle forward-looking items. Let's do it.

Excellent! Now let's record the second watch for the October 2026 CMS Star Ratings.